NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer

Figure 4

NUSAP1 and PCLAF/KIAA0101 gene expression based on microarray data. (a) NUSAP1 gene expression in BS and SS in pCR and (b) non-pCR patients, respectively. (c) PCLAF (Previous symbol KIAA0101) gene expression in BS and SS in pCR and (d) non-pCR (d) patients, respectively. Blue lines and triangles, triple-negative molecular subtype; red lines and squares, luminal A/B molecular subtype; green lines and circles, HER2 molecular subtypes. Two-way ANOVA was performed, and a was considered significant.

(a)

(b)

(c)

(d)